Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12617000902392Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial in scabies comparing Tea tree oil gel with Permethrin control (2 arms). Primary endpoint: Rate of clinical cure or improvement of scabies skin lesions. Planned start Jun 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12617000902392.